CHA Medical & Bio Group

CHA Medical & Bio Group is a South Korea-based biomedical and healthcare group that combines hospitals, fertility centers, academic institutions, translational research, biobanking, and commercial bio businesses under one network. The group is particularly associated with infertility care, stem cell research, regenerative medicine, cell and gene therapy development, and related manufacturing services. Its affiliated businesses include CHA Biotech, Matica Biotechnology, CHA Vaccine Institute, CMG Pharmaceutical, CHA Meditech, and multiple domestic and overseas medical centers. The organization also operates translational R&D through the CHA Advanced Research Institute and has invested heavily in large-scale cell and gene biobanking and CDMO capacity in Korea, alongside viral vector manufacturing operations in the United States. Overall, it functions more as a diversified biomedical group than a single-product biotech, spanning patient care, research, manufacturing, and commercialization.